Rs 212.56 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Eritel CH 6.25 Tablet is a combination medication containing Chlorthalidone and Telmisartan, used to manage high blood pressure. Chlorthalidone acts as a diuretic, helping the body get rid of excess salt and water, while Telmisartan, an angiotensin II receptor blocker, relaxes blood vessels to lower blood pressure. This combination is effective in reducing the risk of cardiovascular events such as stroke and heart attack. It is essential for patients to undergo regular monitoring through blood tests to check electrolytes and kidney function. Common side effects include back pain, sore throat, nausea, abdominal pain, indigestion, and headache. This medication is not recommended for patients with severe liver impairment or anuria and should be used with caution in those with kidney or heart conditions. Consult your healthcare provider for personalized advice and dosage adjustments.
Antihypertensive Combination: Contains Chlorthalidone and Telmisartan to manage high blood pressure. Dual Mechanism: Chlorthalidone is a diuretic; Telmisartan is an angiotensin II receptor blocker. Cardiovascular Protection: Lowers the risk of stroke and heart attack. Kidney and Liver Considerations: Caution in patients with kidney or liver issues. Regular Monitoring: Requires periodic blood tests to monitor electrolytes and kidney function.
ERITEL CH 6.25 TABLET helps lower blood pressure through a dual mechanism. Telmisartan blocks angiotensin, a hormone that regulates blood pressure and fluid balance, resulting in the relaxation of blood vessels. Chlorthalidone works by eliminating excess water and electrolytes from the body, which further helps to relax blood vessels and improve blood flow, thereby reducing high blood pressure.
Take ERITEL CH 6.25 TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
PREGNANCY MONITORING REQUIRED:ERITEL CH 6.25 TABLET is generally not recommended during pregnancy unless absolutely necessary. If you become pregnant while using this medication, consult your doctor and consider discontinuing its use. BREASTFEEDING CONTRAINDICATED:ERITEL CH 6.25 TABLET is not recommended for breastfeeding women, as it may pass into breast milk. Consult your doctor before using this medication. KIDNEY USE WITH CAUTION:Use ERITEL CH 6.25 TABLET with caution if you are undergoing hemodialysis or have kidney issues, such as decreased renal function, severe renal impairment, or nephrogenic diabetes insipidus. Consult your doctor before taking this medication. LIVER CONSULT YOUR DOCTOR:ERITEL CH 6.25 TABLET is not recommended for patients with severe liver impairment. Use with caution if you have mild to moderate liver disease. Consult your doctor before using this medication. ALLERGY CONTRAINDICATED:Do not use ERITEL CH 6.25 TABLET if you are allergic to chlorthalidone, telmisartan, sulfonamide-derived medicines, or any other ingredients in this medication. HEART DISEASE USE WITH CAUTION:Use ERITEL CH 6.25 TABLET with caution if you have heart conditions such as congestive heart failure. Consult your doctor before using this medication. USE IN PEDIATRICS USE WITH CAUTION:Use ERITEL CH 6.25 TABLET with caution in children and adolescents (aged 6 to 18 years). Consult your doctor before administering this medication. USE IN GERIATRICS USE WITH CAUTION:Use ERITEL CH 6.25 TABLET with caution in elderly patients (aged 65 years and older). Consult your doctor before taking this medication.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s